ID

14345

Description

To Evaluate the Inflammatory Markers in Adult Patients With Asthma Associated With Allergic Rhinitis Receiving Montelukast Therapy (0476-366); ODM derived from: https://clinicaltrials.gov/show/NCT00398151

Link

https://clinicaltrials.gov/show/NCT00398151

Keywords

  1. 4/11/16 4/11/16 -
Copyright Holder

CC BY-NC 3.0

Uploaded on

April 11, 2016

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Asthma NCT00398151

Eligibility Asthma NCT00398151

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00398151
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
allergic rhinitis symptoms: sneezing, rhinorrhea, obstruction of the nasal passages, itchy nose and throat, and conjunctival
Description

allergic rhinitis symptoms

Data type

boolean

Alias
UMLS CUI [1,1]
C2607914
UMLS CUI [1,2]
C1457887
UMLS CUI [2]
C0037383
UMLS CUI [3]
C0027429
UMLS CUI [4]
C0850060
UMLS CUI [5]
C0700184
male or female outpatient 20 years of age and older
Description

outpatient, age

Data type

boolean

Alias
UMLS CUI [1]
C0029921
UMLS CUI [2]
C0001779
patients with the following signs and symptoms of asthma and allergic rhinitis: history of cough, wheezing, shortness of breath, positive methacholine bronchoprovocation test
Description

asthma and allergic rhinitis symptoms

Data type

boolean

Alias
UMLS CUI [1]
C0004096
UMLS CUI [2]
C2607914
UMLS CUI [3,1]
C0430567
UMLS CUI [3,2]
C1446409
UMLS CUI [4]
C0010200
UMLS CUI [5]
C0043144
UMLS CUI [6]
C0013404
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
active, acute or chronic, pulmonary disorder (besides asthma) documented by history, physical examination, or chest x-ray. history of anaphylactic or hypersensitive to study drug
Description

pulmonary disorder

Data type

boolean

Alias
UMLS CUI [1]
C1096000
requires oral, intravenous, or intramuscular corticosteroids on daily routine basis
Description

corticosteroids daily

Data type

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C0332173
started on immunotherapy within six months before the pre-study visit and/or the dose of immunotherapy is expected to change over the course of the study
Description

immunotherapy

Data type

boolean

Alias
UMLS CUI [1,1]
C0021083
UMLS CUI [1,2]
C0040223
treated with montelukast within 3 months before enrollment
Description

montelukast

Data type

boolean

Alias
UMLS CUI [1]
C0298130
unable to perform acceptable, reproducible spirometry and peak flow measurement
Description

unable to perform acceptable, reproducible spirometry and peak flow measurement

Data type

boolean

Alias
UMLS CUI [1]
C1321605
UMLS CUI [2]
C0037981
UMLS CUI [3]
C0521299
unresolved symptoms and signs of an upper respiratory tract infection (uri) within 2 weeks prior to visit 1
Description

upper respiratory tract infection

Data type

boolean

Alias
UMLS CUI [1]
C0041912

Similar models

Eligibility Asthma NCT00398151

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00398151
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
allergic rhinitis symptoms
Item
allergic rhinitis symptoms: sneezing, rhinorrhea, obstruction of the nasal passages, itchy nose and throat, and conjunctival
boolean
C2607914 (UMLS CUI [1,1])
C1457887 (UMLS CUI [1,2])
C0037383 (UMLS CUI [2])
C0027429 (UMLS CUI [3])
C0850060 (UMLS CUI [4])
C0700184 (UMLS CUI [5])
outpatient, age
Item
male or female outpatient 20 years of age and older
boolean
C0029921 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
asthma and allergic rhinitis symptoms
Item
patients with the following signs and symptoms of asthma and allergic rhinitis: history of cough, wheezing, shortness of breath, positive methacholine bronchoprovocation test
boolean
C0004096 (UMLS CUI [1])
C2607914 (UMLS CUI [2])
C0430567 (UMLS CUI [3,1])
C1446409 (UMLS CUI [3,2])
C0010200 (UMLS CUI [4])
C0043144 (UMLS CUI [5])
C0013404 (UMLS CUI [6])
Item Group
C0680251 (UMLS CUI)
pulmonary disorder
Item
active, acute or chronic, pulmonary disorder (besides asthma) documented by history, physical examination, or chest x-ray. history of anaphylactic or hypersensitive to study drug
boolean
C1096000 (UMLS CUI [1])
corticosteroids daily
Item
requires oral, intravenous, or intramuscular corticosteroids on daily routine basis
boolean
C0001617 (UMLS CUI [1,1])
C0332173 (UMLS CUI [1,2])
immunotherapy
Item
started on immunotherapy within six months before the pre-study visit and/or the dose of immunotherapy is expected to change over the course of the study
boolean
C0021083 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
montelukast
Item
treated with montelukast within 3 months before enrollment
boolean
C0298130 (UMLS CUI [1])
unable to perform acceptable, reproducible spirometry and peak flow measurement
Item
unable to perform acceptable, reproducible spirometry and peak flow measurement
boolean
C1321605 (UMLS CUI [1])
C0037981 (UMLS CUI [2])
C0521299 (UMLS CUI [3])
upper respiratory tract infection
Item
unresolved symptoms and signs of an upper respiratory tract infection (uri) within 2 weeks prior to visit 1
boolean
C0041912 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial